Dual-peptide blend: BPC-157 (15-aa pentadecapeptide) + TB-500 (43-aa active fragment of Thymosin Beta-4) The pathways BPC-157 / TB-500 acts on and what each one does

Potential Benefits of AOD-9604 Targeted Fat Reduction Directly stimulates the breakdown of stored fat in adipose tissue, particularly in stubborn areas resistant to diet and exercise Inhibited Fat Formation Prevents the creation of new fat cells, supporting long-term body composition improvements beyond initial fat loss No Blood Sugar Impact Does not affect glucose metabolism or insulin sensitivity, making it safe for patients concerned about metabolic disruption No IGF-1 Stimulation Avoids the cell proliferation effects associated with full HGH therapy while retaining the fat-specific benefits Improved Body Composition Helps shift the ratio of fat to lean tissue for a more defined, healthier physique Complementary to Diet and Exercise Enhances results from nutrition and training programs by targeting fat at the cellular level Potential Joint Support Emerging research suggests AOD-9604 may support cartilage health and repair Well-Tolerated Safety Profile Decades of research support AOD-9604's safety for fat reduction applications without significant adverse effects What Is AOD-9604 For

For example, in arterial hypertension, increased reactive oxygen species (ROS) and pro-inflammatory cytokines are regulated by histone deacetylase (HDAC) enzymes, which modulate the gene expression of these hypertension-promoting factors
Improves energy metabolism to ensure the efficient release of energy necessary for optimal muscle function and optimal oxygen carrying capacity of red blood cells for muscle perfusion
GLP-1 agonists are highly regulated, FDA-approved prescription medications with defined dosing protocols and monitored side-effect profiles
Some people require regular doses over time, while others may only need short-term treatment to restore their levels